Clinical Trial Update: Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing lutein, zeaxanthin, and omega-3 supplementation in people over 60 with macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein (lutein)
• Omega-3 fatty acids (omega-3 fatty acids)
• Zeaxanthin (Zeaxanthin)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED